Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Evaluation in Vivo of Dentifrice With Nanoencapsulated Fluoride

29 dicembre 2016 aggiornato da: Fabio Correia Sampaio

Evaluation in Vivo of Experimental Dentifrice With Nanoencapsulated Fluoride

The literature recognizes that fluoride is the most widely used and studied means for dental remineralization. The use of fluoride toothpaste in brushing is considered more rational method for the prevention of caries. However, the current challenge of toothpaste is the substantivity, so new compounds have been introduced into these formulations. This study aims to evaluate the in vivo effect of fluoride dentifrice containing nanoencapsulated Fluoride (Nano-F) - in fluoride retention in saliva and dental plaque. A study of the clinical and laboratory type, crossover, double-blind, randomized will be held. After sample calculation, the total of 12 individuals aged between 18 and 35 years old, healthy, decayed, missing, and filled teeth index less than 6 and residents in brazilian northeast capital will be part of the sample. Fluoride bioavailability will be evaluated in the biofilm and saliva after the use of fluoridated weekly. The biofilm will be assessed on 1h and 12 h after brushing; and unstimulated saliva in times of 3, 15, 30, 45, 60 minutes and 12 hours after. It will be 3 toothpastes: 50% Nanoencapsulated Fluoride, 100% Nanoencapsulated Fluoride and Free sodium fluoride. Between weeks of use, brushing will be extended washout (without fluoride) to avoid carryover effect. inferential data analysis will be carried out, considering the amount of alpha <0.05. So knowing that caries is a dynamic process, the largest fluoride retention in the oral fluids promoted by the Nanoencapsulated Fluoride may have important impact on Des-Re process and in the control of dental caries

Panoramica dello studio

Descrizione dettagliata

  1. Study design It is a quantitative study of double-blind randomized crossover clinical type with inductive approach and documentation of technical and direct observation with measurements in the laboratory.

    In order to assess the bioavailability of intraoral fluoride week after the use of fluoride toothpastes containing Nanoencapsulated Fluoride, it will be collected biofilm samples 1h and 12 h after brushing; and unstimulated saliva in times of 3, 15, 30, 45, 60 minutes and 12 hours after. The data will be obtained by physical and chemical analysis of the samples of fluoride (F). Therefore, the study will consist of two interrelated steps: a clinical phase for biofilm collection and saliva; and laboratory stage for fluoride analysis in the samples.

    Will be conducted pilot test with three participants before the start of the study.

  2. Sample Size The sample size calculation was performed using fluoride concentration data in dental biofilm previous study and taking effect size difference between the experimental dentifrice (100% Nanoencapsulated Fluoride ) and positive control of at least 3.4 ppm of F- in biofilm after 12 hours, namely, 25%. Admitting experimental protocol with beta error of 10% alpha error of 5%, one-tailed and statistical power of 90%, the sample size was calculated for 6 people. For the calculation we used the Excel software and mathematical formula for clinical trials of superiority given. Adding sample loss resulted in 12 people.
  3. Experimental Dentifrice For this study will be used four toothpastes: 50% Nanoencapsulated Fluoride, 100% Nanoencapsulated Fluoride, Free sodium fluoride, Without fluoride. The toothpaste, made available by the company from Brazil are packed in the same packaging and have the taste of mint. Except wash out the tubes with toothpaste will be identified by letters (A, B and C) by an independent researcher. The letters code will not be revealed to the participants nor the researcher who will accompany them. These will be drawn at random for daily use for seven days in four times, giving an interval of one week wash-out between them.

    In these periods of wash-out will use a toothpaste without fluoride. In the end, all study participants will use the 5 experimental dentifrice at different times.

  4. Clinical phase The participant will be informed about the study and after its acceptance, he/she will initiate the study. Initially will be clinical examination in order to report the presence of any of the exclusion criteria already listed. After verifying the absence of these criteria, there will be a dental prophylaxis pumice for removal of this biofilm and in some cases may be made supragingival scraping. The patient will be advised not to make use of any fluoride product during the experiment. At first, volunteers are instructed to use a toothpaste without fluoride (wash out) the first week, in order to equate the study participants and eliminate any potential carryover effects of toothpaste used previously.

    The participant will get a tube of toothpaste and will be instructed to brush their teeth for 1 minute and rinse with 10 mL of water twice a day (morning and night). On the seventh day, the participant will be instructed to brush only the occlusal surfaces of your teeth, to allow biofilm accumulation of flat surfaces. When going to bed, you are warned not to eat or drink (except water) as well as not brushing your teeth until the next day. On the following morning, approximately 12 hours after the last brushing and fasting, the first dental biofilm sample and unstimulated saliva is collected. It will be used to remove biofilm Hollenback vestibular faces, interproximal, palatal and lingual right hemiarch and deposited in a pre-weighed Eppendorf tube in an analytical balance. To saliva collection, the participant, at rest, will be instructed to spit for a minute in a graduated glass tube. After that, the participant will brush the occlusal surfaces for 1 min and rinse with 10 mL of water. Soon after, will new collection of saliva and plaque. Saliva samples will give up in times of 3, 15, 30, 45 and 60 minutes after brushing, while the biofilm left hemiarch will be collected one hour after brushing. After the collection will be offered at breakfast organized by researchers participating in the crown of that research center.

  5. Laboratorial phase Samples will be evaluated through physical-chemical analysis of fluoride using calibrated fluoride electrode. Samples will be analyzed for fluoride concentration using ion-specific electrode after diffusion facilitated with hexamethyl disiloxane (HMDS). The calibration curve is made for each analysis. All analyzes will be done in triplicate and be submitted for validation.
  6. Data analysis The study data will be analyzed by inferential statistics considering p <0.05.

Tipo di studio

Interventistico

Iscrizione (Anticipato)

20

Fase

  • Fase 2
  • Fase 1

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Paraíba
      • Joao Pessoa, Paraíba, Brasile
        • Federal University of Paraíba

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 32 anni (Adulto)

Accetta volontari sani

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • resident in João Pessoa
  • Decayed, Missing, Filled Index<6
  • Healthy

Exclusion Criteria:

  • orthodontic treatment
  • gingivitis
  • Periodontal disease
  • Smokers
  • Present active tooth decay
  • Tooth sensitivity
  • Those undergoing treatment with fluoride products and / or use of antimicrobials in the past four weeks

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Triplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore placebo: Placebo
Dentifrice without fluoride
Use of few of dentifrice 100% Nanoencapsulated Fluoride on brushing for one week, twice day.
Use of few of dentifrice 50% Nanoencapsulated Fluoride on brushing for one week, twice day.
Use of few of dentifrice on brushing for one week, twice day. It's for the positive control of fluorid
Comparatore attivo: Dentifrice standard
Dentifrice 1100 ppm sodium fluoride (NaF). Positive control
Use of few of dentifrice on brushing for one week, twice day. It's for the positive control of fluorid
Sperimentale: Dentifrice 50% Nano-F
Dentifrice experimental with Fluoride being half of fluoride Nanoencapsulated and other half freeform of NaF
Use of few of dentifrice 50% Nanoencapsulated Fluoride on brushing for one week, twice day.
Sperimentale: Dentifrice 100% Nano-F
Dentifrice experimental with fluoride 100% Nanoencapsulated
Use of few of dentifrice 100% Nanoencapsulated Fluoride on brushing for one week, twice day.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Bioavailability of intraoral fluoride (biofilm and saliva)
Lasso di tempo: six months
collection of dental plaque(biofilm) and saliva
six months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Direttore dello studio: Fábio Sampaio, Doctor, University Federal of Paraiba

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio

1 febbraio 2016

Completamento primario (Effettivo)

1 novembre 2016

Completamento dello studio (Anticipato)

1 febbraio 2017

Date di iscrizione allo studio

Primo inviato

25 novembre 2016

Primo inviato che soddisfa i criteri di controllo qualità

29 dicembre 2016

Primo Inserito (Stima)

2 gennaio 2017

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Stima)

2 gennaio 2017

Ultimo aggiornamento inviato che soddisfa i criteri QC

29 dicembre 2016

Ultimo verificato

1 novembre 2016

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • NanoF

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Carie dentale

Prove cliniche su Dentifrice 100% Nano-F

Sottoscrivi